• Regulatory NewsRegulatory News

    Influential FDA Drug Policy Office Gets New Leader

    The US Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) has announced the hire of a new leader for its Office of Medical Policy (OMP), an influential office tasked with developing the agency's pharmaceutical policies. Background The 150-person office is influential within FDA, and describes itself as the "driving force" behind drug policy development at the agency. Major policies recently developed and implemented by OMP include FDA's ...
  • Regulatory NewsRegulatory News

    FDA, in Midst of Developing Biosimilars Policy, Seeks Permanent Medical Policy Director

    The US Food and Drug Administration (FDA) is seeking a new director for the Center for Drug Evaluation and Research's (CDER) Office of Medical Policy (OMP). The position has previously been held by FDA's Rachel Sherman, and is now held by Acting Director Capt. Denise Hinton . The 150-person office is influential within FDA, and describes itself as the "driving force" behind drug policy development at the agency. Hinton's agency profile notes that the office is involved ...